Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open, Phase 2 Study to Evaluate the Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis

NCT05540587 is registered in ClinicalTrials.gov with Sung-Hwan Kim as lead sponsor.

NCT NCT05540587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05540587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open, Phase 2 Study to Evaluate the Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis
Lead sponsor
Sung-Hwan Kim
Phase
Phase 2
Overall status
Unknown status
Start date
May 20, 2022
Completion date
May 20, 2026
Enrollment
240 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, mitral valve stenosis, stroke, systemic embolism